HTA in the nutritional care: investments’ efficiency and effectiveness

Journal title RIVISTA DI STUDI SULLA SOSTENIBILITA'
Author/s Alberto Manelli, Oscar Domenichelli, Roberta Pace, Martina Vallesi
Publishing Year 2017 Issue 2016/2 Language English
Pages 12 P. 57-68 File size 159 KB
DOI 10.3280/RISS2016-002006
DOI is like a bar code for intellectual property: to have more infomation click here

Below, you can see the article first page

If you want to buy this article in PDF format, you can do it, following the instructions to buy download credits

Article preview

FrancoAngeli is member of Publishers International Linking Association, Inc (PILA), a not-for-profit association which run the CrossRef service enabling links to and from online scholarly content.

Health Technology Assessment (HTA) in spite of being a relatively recent methodological phenomenon has become increasingly important tool for the policy makers to bridge the gap between research and policy making. This work starts with an evaluation of the logic behind the adoption of HTA process for policy making, including features and advantages of the process. Subsequently, this study presents the risk related to the investments in health sector, from the different prospectives such as: balance among effectiveness, efficiency and economy; and role of the scarcity of available resources. Finally, the explanation about the necessity to evaluate the ability of investments in the health technology in nutritional care making a synthesis between the different variables to support the operations of the policy makers in a view to create added value and to contain costs.

Keywords: Health technologies, nutrition, evaluation, efficiency, effectiveness, value

  1. Banta H.D., Luce B.R. (1993). Heath care technology and its assessment: an international perspective. New York: Oxford University Press.
  2. Banta D. (2003). The development of health technology assessment. Health Policy, 63(2): 121-32. DOI: 10.1016/S0168-8510(02)00059-3
  3. Battista R.N., Hodge M.J. (1999). The evolving paradigm of health technology assessment: reflections for the millennium. Canadian Medical Association Journal, 160(10): 1464-67.
  4. Ciaschini M., Socci C., Pretaroli R. (2009). Contenimento della spesa corrente e spesa in conto capitale nel sistema sanitario pubblico, Tendenze Nuove, 2.
  5. Corte dei Conti. Relazione sulla gestione finanziaria per l’esercizio 2013 degli enti territoriali.
  6. Davies P. (2005). Evidence-based policy at the cabinet office, Presentation at the impact and insight seminar, 17 October 2005. London, Overseas Development Institute, – http://www.odi.org.uk/rapid/Events/Impact_Insight/docs/Phil_Davies.ppt., visitato il 20 gennaio 2015: 11.
  7. European Network for Health Technology Assessment (EUnetHTA) (2008). EUnetHTA Handbook on HTA Capacity Building, October, Work Package 8.
  8. European Network for Health Technology Assessment (EUnetHTA) (2012). EUnetHTA Strategy 2012 and beyond, May 24, 2012 – https://eunethta.fedimbo.belgium.be /outputs / eunethta-strategy-2012-and-beyond, visitato il 23 febbraio 2015: 5.
  9. Florio M. (2006). La valutazione degli investimenti pubblici: i progetti di sviluppo nell’Unione europea e nell’esperienza internazionale, Milano: FrancoAngeli.
  10. Garrido M.V., Zentner A., Busse R. (2008). Health systems, health policy and health technology assessment. In: Garrido M.V., Kristensen F.B., Nielsen C.P., Busse R. (2008). Health technology assessment and health policy-making in Europe. Observatory studies series n. 14, World Health Organisation, on behalf of the European Observatory on Health Systems and Policies.
  11. Geisler E., Heller O. (1998). Management of medical technology. Theory, practice and cases. Boston: Kluwer Academic Publications.
  12. Kanavos P. (2009). Il futuro dell’Health Technology Assessment. In: Agenas, 4° Supplemento al numero 23, 2009, di Monitor – Trimestrale dell’Agenzia nazionale per i servizi sanitari regionali, Roma.
  13. McIntosh M.E., Donaldson C., Ryan M. (1999). Recent advances in the methods of cost-benefit analysis in healthcare. Pharmacoeconomics, 15(4): 357-367. DOI: 10.2165/00019053-199915040-00003
  14. Mehrez A., Gafni A. (1989). Quality-adjusted life years, utility theory, and healthy-years equivalents. Medical decision making, 9(2): 142-149. DOI: 10.1177/0272989X8900900209
  15. Nielsen C.P., Santamera A.S., Vondeling H. (2008). Policy processes and health technology assessment. In: Garrido M.V., Kristensen F.B., Nielsen C.P., Busse R. (2008). Health technology assessment and health policy-making in Europe, Observatory studies series n. 14, World Health Organisation, on behalf of the European Observatory on Health Systems and Policies.
  16. Organisation for Economic Co-operation and Development (OECD) (2005). Health technologies and decision making, The OECD Health Project.
  17. Reisman A. (1996). Management technologies for managing the heath care sector technologies. In: Geisler E., Heller O. (eds.). Managing Technologies in Health Care. Norwell, MA: Kluwer Academic Publishers. DOI: 10.1007/978-1-4613-1415-8_6
  18. Weinstein M.C., Stason W.B. (1977). Foundations of cost-effectiveness analysis for health and medical practices. New England journal of medicine, 296(13): 716-721. DOI: 10.1056/NEJM197703312961304

Alberto Manelli, Oscar Domenichelli, Roberta Pace, Martina Vallesi, HTA in the nutritional care: investments’ efficiency and effectiveness in "RIVISTA DI STUDI SULLA SOSTENIBILITA'" 2/2016, pp 57-68, DOI: 10.3280/RISS2016-002006